A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns ...
Abstract: This article addresses the challenge of scheduling multiple output priority queues of a switch in a real-world setting characterized by bursty traffic and diverse traffic priorities. The ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
ABSTRACT: This article highlights the relevance of queuing theory as a decision-making tool for solving congestion problems in Guinean ports, particularly of the Autonomous Port of Conakry (APC). Port ...
FDA assigned PDUFA target action date of July 7, 2026. If approved, atacicept would be the first B cell modulator targeting both BAFF and APRIL for IgAN. Atacicept received FDA Breakthrough Therapy ...
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...
WASHINGTON (AP) — The Trump administration has instructed U.S. embassies and consulates around the world to prioritize visa applications from foreigners wishing to visit the United States to either ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca’s New Drug Application (NDA) for baxdrostat has been accepted for Priority Review by the US Food and Drug Administration (FDA) in the US for the ...
TEL AVIV, Israel, Nov. 19, 2025 /CNW/ -- Priority Software Ltd., a leading global provider of AI-based cloud ERP and business management solutions, has been recognized as a Major Player in the IDC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results